BioCryst Pharmaceuticals Inc (BCRX) Insider Trading
- $10,606,554.40
- $40,886,919.76
- June 24, 2024
- Thomas R Staab II
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
Jan. 16, 2019 | VP | 3,046 | $9.27 | Sell | $28,236.42 | |
Jan. 14, 2019 | VP | 954 | $9.20 | Sell | $8,776.80 | |
Dec. 18, 2018 | CMO | 20,488 | $7.58 | Sell | $155,299.04 | |
Dec. 10, 2018 | VP | 4,000 | $9.06 | Sell | $36,240.00 | |
Dec. 4, 2018 | Insider | 3,922 | $9.45 | Sell | $37,062.90 | |
Nov. 30, 2018 | VP | 44,290 | $9.07 | Sell | $401,710.30 | |
Nov. 23, 2018 | Insider | 15,500 | $9.32 | Sell | $144,460.00 | |
Nov. 20, 2018 | VP | 15,470 | $8.55 | Sell | $132,268.50 | |
Nov. 20, 2018 | Insider | 11,198 | $8.67 | Sell | $97,086.66 | |
Nov. 8, 2018 | VP | 5,280 | $8.15 | Sell | $43,032.00 | |
Nov. 8, 2018 | Insider | 14,087 | $8.12 | Sell | $114,386.44 | |
Nov. 5, 2018 | Insider | 215 | $8.00 | Sell | $1,720.00 | |
Nov. 5, 2018 | VP | 100 | $8.00 | Sell | $800.00 | |
Nov. 2, 2018 | CFO | 10,856 | $7.84 | Sell | $85,111.04 | |
Nov. 1, 2018 | VP | 1,544 | $7.51 | Sell | $11,595.44 | |
Oct. 19, 2018 | VP | 100 | $7.50 | Sell | $750.00 | |
Oct. 19, 2018 | Insider | 3,150 | $7.45 | Sell | $23,467.50 | |
Oct. 3, 2018 | Insider | 9,850 | $7.24 | Sell | $71,314.00 | |
Aug. 9, 2018 | CMO | 62,500 | $7.03 | Sell | $439,375.00 | |
June 1, 2018 | CMO | 42,112 | $6.30 | Sell | $265,305.60 | |
Nov. 13, 2017 | CMO | 64,310 | $4.72 | Sell | $303,543.20 | |
Sept. 18, 2017 | Director | 54,250 | $5.42 | Sell | $294,035.00 | |
March 20, 2017 | CFO | 3,250 | $9.20 | Sell | $29,900.00 | |
March 10, 2017 | Insider | 3,250 | $9.06 | Sell | $29,445.00 | |
March 8, 2017 | Insider | 6,500 | $8.43 | Sell | $54,795.00 | |
March 6, 2017 | Insider | 3,250 | $7.90 | Sell | $25,675.00 | |
Dec. 19, 2016 | Insider | 3,250 | $7.45 | Sell | $24,212.50 | |
Sept. 14, 2016 | VP | 8,357 | $4.27 | Sell | $35,684.39 | |
Aug. 25, 2016 | VP | 30,000 | $4.06 | Sell | $121,800.00 | |
Aug. 16, 2016 | Major Shareholder | 4,046,590 | $5.00 | Sell | $20,232,950.00 | |
Aug. 12, 2016 | Insider | 5,864 | $5.18 | Sell | $30,375.52 | |
Aug. 9, 2016 | Insider | 14,577 | $4.43 | Sell | $64,576.11 | |
Jan. 28, 2016 | major shareholder | 88,345 | $6.95 | Buy | $613,997.75 | |
Jan. 22, 2016 | major shareholder | 106,800 | $7.28 | Buy | $777,504.00 | |
Jan. 20, 2016 | major shareholder | 52,695 | $6.87 | Buy | $362,014.65 | |
Jan. 19, 2016 | major shareholder | 92,200 | $7.12 | Buy | $656,464.00 | |
Jan. 15, 2016 | major shareholder | 200,000 | $7.46 | Buy | $1,492,000.00 | |
Dec. 21, 2015 | CFO | 3,052 | $10.86 | Sell | $33,144.72 | |
Dec. 17, 2015 | CFO | 3,000 | $10.49 | Sell | $31,470.00 | |
July 20, 2015 | CFO | 3,500 | $16.50 | Sell | $57,750.00 | |
June 22, 2015 | CFO | 3,750 | $16.00 | Sell | $60,000.00 | |
June 19, 2015 | CFO | 16,375 | $14.36 | Sell | $235,145.00 | |
June 19, 2015 | VP | 3,000 | $15.00 | Sell | $45,000.00 | |
June 19, 2015 | CEO | 20,000 | $15.02 | Sell | $300,400.00 | |
June 19, 2015 | CMO | 70,389 | $15.05 | Sell | $1,059,354.45 | |
June 5, 2015 | CFO | 6,000 | $12.75 | Sell | $76,500.00 | |
May 18, 2015 | CFO | 3,000 | $11.00 | Sell | $33,000.00 | |
March 19, 2015 | VP | 12,105 | $10.16 | Sell | $122,986.80 | |
March 5, 2015 | VP | 37,400 | $10.59 | Sell | $396,066.00 | |
March 4, 2015 | VP | 10,495 | $10.50 | Sell | $110,197.50 |
Insiders are both buying and selling BioCryst Pharmaceuticals Inc stock.
The insider traders at BioCryst Pharmaceuticals Inc are: Thomas R Staab II, Lynne Powell, William P Sheridan, Alane P Barnes, Bros. Advisors Lp Baker, George B Abercrombie, Jon P Stonehouse, Yarlagadda S Babu, Anthony Doyle, Helen M Thackray, Nancy J Hutson, Steve Aselage, Machelle Sanders, Michael L Jones, Peder Jensen, Steven K Galson, Amy E Mckee, Thomas Staab II, Felix Baker, Fred E Cohen, Vincent Milano, George Abercrombie, George B. Abercrombie, Alan G Levin, Kenneth B Lee Jr, Kenneth Lee, Jr., and Megan Sniecinski
The most active insider trader at BioCryst Pharmaceuticals Inc is Thomas R Staab II with 35 trades.
Bros. Advisors Lp Baker has sold the most BioCryst Pharmaceuticals Inc stock with a total value of $40,465,900.00.
Felix Baker has bought the most BioCryst Pharmaceuticals Inc stock with a total value of $10,000,003.20.
The most recent insider trade for BioCryst Pharmaceuticals Inc was on June 24, 2024.
The single biggest insider buy for BioCryst Pharmaceuticals Inc was from Felix Baker with a total value of $5,000,001.60 on Aug. 1, 2013.
The single biggest insider sell for BioCryst Pharmaceuticals Inc was from Bros. Advisors Lp Baker with a total value of $20,232,950.00 on Aug. 16, 2016.